# Pulmicort Asthma Prevention (Post-PAC)

> **NCT00233584** · NA · COMPLETED · sponsor: **AstraZeneca** · enrollment: 400 (—)

## Conditions studied

- Asthma

## Interventions

- **PROCEDURE:** Pulmicort (budesonide) pMDI

## Key facts

- **NCT ID:** NCT00233584
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-05
- **Final completion:** 2006-06
- **Target enrollment:** 400 (—)
- **Last updated:** 2008-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233584, "Pulmicort Asthma Prevention (Post-PAC)". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00233584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*